RT Journal Article
SR Electronic
T1 Association of single nucleotide polymorphisms in <em>XRCC1</em> and <em>ATM</em> with recurrence in patients with cervical cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.26.21256088
DO 10.1101/2021.04.26.21256088
A1 Soo Youn Cho
A1 Kidong Kim
A1 Sang Young Ryu
A1 Moon-Hong Kim
A1 Beob-Jong Kim
YR 2021
UL http://medrxiv.org/content/early/2021/04/28/2021.04.26.21256088.abstract
AB Objective The primary objective of this study was to determine the association of the genotype of X-ray repair complementing defective repair in Chinese hamster cell 1 (XRCC1) 580C&gt;T with recurrence-free survival (RFS) in patients with cervical cancer who underwent radical surgery followed by adjuvant concurrent chemoradiation (CRT). Secondary objectives were to assess 1) the association of single nucleotide polymorphisms (SNPs) in XRCC1 and ataxia telangiectasia mutated (ATM) gene with RFS, overall survival (OS) and completion of CRT, 2) the association of haplotypes of XRCC1 and ATM with RFS, OS and completion of CRT, 3) concordance rate between genotypes from cancer tissue and that from normal tissue and 4) the association of clinicopathologic variables with RFS and OS.Materials and Methods Clinicopathologic variables were extracted from medical records of 159 patients who underwent radical hysterectomy followed by adjuvant CRT in a cancer center between 1999 and 2004. After exclusion of six patients without paraffin blocks, 153 patients were included in this study. DNA was extracted from a formalin-fixed, paraffin embedded tissue block containing tumor tissue and another block containing uninvolved lymph node. Genotyping for XRCC1 580C&gt;T (rs 1799782), XRCC1 1196A&gt;G (rs 25487), ATM 3078-77C&gt;T (rs 664677), ATM 5557G&gt;A (rs 1801516) and ATM 6807+238G&gt;C (rs609429) was performed using pyrosequencing. Haplotype estimation was performed using haplo.stats in R version 2.15.0. The association of genotype or haplotype of SNPs with RFS, OS and completion of CRT was evaluated via Cox regression analysis, chi-square or Fisher’s exact test. The concordance rate between genotype from cancer tissue and that from normal tissue was examined according to SNP. The association of clinicopathologic variables with RFS and OS was estimated via Cox regression analysis.Results None of SNPs was associated with RFS, OS and completion of CRT. Concordance rate between genotype from cancer tissue and that from normal tissue for XRCC1 580C&gt;T, XRCC1 1196A&gt;G, ATM 3078-77C&gt;T, ATM 5557G&gt;A and ATM 6807+238G&gt;C were 72%, 88%, 73%, 100% and 54%, respectively. Age, stage, histologic type, LVSI and parametrial invasion were associated with RFS, and clinical tumor size, resection margin, lymph node involvement and completion of CRT were associated with OS.Conclusion Genotype of XRCC1 580C&gt;T was not associated with RFS in patients with cervical cancer who underwent radical surgery followed by adjuvant CRT. Low concordance rate between cancer and germline genotype was identified in cervical cancer.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the intramural research fund of Korea Institute of Radiological &amp; Medical Sciences.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The KIRAMS Institutional Review Board approved the study protocol and waived the acquisition of informed consent(K-1101-002-058).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be provided upon reasonable requests.